Phase I trial expectations ‘unrealistic’

Cancer patients who are considering participating in phase I clinical trials have “unrealistic expectations” of the benefits, a new study out today has found.

The research by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, which explored patients’ motivations for considering phase I trials and assessed their expectations both before and after they consulted with clinicians, found that almost half thought their tumours would shrink.

The revelation, published in CANCER, demonstrate the challenges facing patients and healthcare professionals during their interactions in phase I studies, say the authors.

A total of 396 patients who were considering participating in a phase I clinical trial completed questionnaires prior to being seen by a doctor, and 301 completed an abbreviated follow-up questionnaire after consultation with clinicians.

Dr Udai Banerji, who led the research, and team found that when the patients were asked about the potential personal benefit of participating, 43% predicted tumour shrinkage in the initial questionnaire.

Following a consultation, this increased to 47%, which shows that existing methods of communication did not lessen patients’ pre-consultation expectations of benefit, he said.

Overall, patients were keen to consider trials, with 72% of pre- and 84% of post-clinic patients willing to enrol.

“There is a positive message in this, which is that 84% of patients are willing to participate in phase I oncology studies after a discussion with clinical and nursing staff who lay out the conservative estimates of benefit and requirements of hospital visits,” said Dr Banerji.

“This is good for current and future patients and cancer medicine in general. The high percentage of patients expecting their tumours to shrink was a sobering finding. This creates a challenge for healthcare professionals to manage expectations but to do so without being patronising or dismissing human hope.”

The results also demonstrate the need to improve patient information and consent forms, he added.

Dolly S, Kalaitzaki E, Puglisi M et al. A study of the motivations and expectations of patients seen in phase I oncology clinics. CANCER. 26 September 2016; doi: 10.1002/cncr.30235.

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index